Changes to expert opinion in the use of antirheumatic drugs before and during pregnancy five years after EULAR: points to consider

Rheumatology (Oxford). 2022 Nov 2;61(11):e331-e333. doi: 10.1093/rheumatology/keac262.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antirheumatic Agents* / therapeutic use
  • Arthritis, Rheumatoid* / drug therapy
  • Expert Testimony
  • Female
  • Humans
  • Pregnancy

Substances

  • Antirheumatic Agents